Last edition
News about "Qiming Venture Partners "
Syneron Bio Raises USD 150 Million in Series B Funding
Syneron Bio raises USD 150 million in Series B to advance its Synova macrocyclic peptide platform and accelerate pipeline development towards clinical stages.
Qiming Venture Partners | 06/04/2026 | By News Bureau
Oricell Therapeutics Raises USD 70M in Series C1 to Advance CAR-T Therapies for Solid Tumors
The funding will accelerate global expansion and clinical development of Oricell’s CAR-T pipeline, including its lead hepatocellular carcinoma programme Ori-C101.
Qiming Venture Partners | 13/01/2026 | By News Bureau | 213
Convergen Raises USD 10 Million Seed Funding to Advance TrimTAC Platform
Convergen has raised USD 10 million in seed funding from Qiming Venture Partners to speed up development of its TrimTAC platform—novel TRIM21-based bifunctional degraders—and advance its early pipeline targeting neurodegenerative and other high-need diseases.
Qiming Venture Partners | 09/12/2025 | By Akanki | 133
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy